In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Vein access device effective in early study:

This article was originally published in Clinica

Executive Summary

An implantable device which provides access to the veins of haemodialysis patients has worked well in a preliminary study of patients at the Austin Diagnostic Center in Texas. The LifeSite device, a stainless steel and titanium alloy valve implanted just under the skin, was developed by Topsfield, Massachusetts-based VascA. According to the results of the study, it allowed increased blood flow and was free from thrombosis in all ten patients. The device, which is already sold in Canada and Europe, is designed as an alternative to fistulas, synthetic grafts and dialysis catheters.

You may also be interested in...

Big Data Offers International Benefits

The HMA-EMA Big Data Task Force has offered recommendations to use data for the benefit of public health.

Spin-Out A Neat Solution For Sanofi’s Manufacturing Millstone

Stada Grabs GSK Brands In Key EU Markets

Stada says it has become a "major consumer healthcare player" after signing a deal to acquire from GSK 15 brands, which generate annual sales in excess of €100m.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts